HEADER RIBOSOMAL PROTEIN 27-MAR-07 2PA2 TITLE CRYSTAL STRUCTURE OF HUMAN RIBOSOMAL PROTEIN L10 CORE DOMAIN COMPND MOL_ID: 1; COMPND 2 MOLECULE: 60S RIBOSOMAL PROTEIN L10; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: CORE DOMAIN; COMPND 5 SYNONYM: QM PROTEIN, TUMOR SUPPRESSOR QM, LAMININ RECEPTOR HOMOLOG; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PET32B-L10CD KEYWDS RIBOSOMAL PROTEIN L10, QM PROTEIN, STRUCTURAL GENOMICS, NPPSFA, KEYWDS 2 NATIONAL PROJECT ON PROTEIN STRUCTURAL AND FUNCTIONAL ANALYSES, KEYWDS 3 RIKEN STRUCTURAL GENOMICS/PROTEOMICS INITIATIVE, RSGI, RIBOSOMAL KEYWDS 4 PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR M.NISHIMURA,T.KAMINISHI,C.TAKEMOTO,M.KAWAZOE,T.YOSHIDA,A.TANAKA, AUTHOR 2 S.SUGANO,M.SHIROUZU,T.OHKUBO,S.YOKOYAMA,Y.KOBAYASHI,RIKEN STRUCTURAL AUTHOR 3 GENOMICS/PROTEOMICS INITIATIVE (RSGI) REVDAT 5 25-OCT-23 2PA2 1 REMARK REVDAT 4 06-NOV-19 2PA2 1 KEYWDS SEQADV REVDAT 3 24-FEB-09 2PA2 1 VERSN REVDAT 2 18-MAR-08 2PA2 1 JRNL REVDAT 1 11-MAR-08 2PA2 0 JRNL AUTH M.NISHIMURA,T.KAMINISHI,C.TAKEMOTO,M.KAWAZOE,T.YOSHIDA, JRNL AUTH 2 A.TANAKA,S.SUGANO,M.SHIROUZU,T.OHKUBO,S.YOKOYAMA,Y.KOBAYASHI JRNL TITL CRYSTAL STRUCTURE OF HUMAN RIBOSOMAL PROTEIN L10 CORE DOMAIN JRNL TITL 2 REVEALS EUKARYOTE-SPECIFIC MOTIFS IN ADDITION TO THE JRNL TITL 3 CONSERVED FOLD JRNL REF J.MOL.BIOL. V. 377 421 2008 JRNL REFN ISSN 0022-2836 JRNL PMID 18258260 JRNL DOI 10.1016/J.JMB.2008.01.003 REMARK 2 REMARK 2 RESOLUTION. 2.50 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.50 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 45.66 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 890089.430 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 98.1 REMARK 3 NUMBER OF REFLECTIONS : 10814 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.240 REMARK 3 FREE R VALUE : 0.264 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.200 REMARK 3 FREE R VALUE TEST SET COUNT : 567 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.011 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.50 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.66 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 95.40 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 1593 REMARK 3 BIN R VALUE (WORKING SET) : 0.3480 REMARK 3 BIN FREE R VALUE : 0.3880 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 6.10 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 103 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.038 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1750 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 2 REMARK 3 SOLVENT ATOMS : 35 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 60.00 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 56.40 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 11.58000 REMARK 3 B22 (A**2) : 11.58000 REMARK 3 B33 (A**2) : -23.16000 REMARK 3 B12 (A**2) : 7.78000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.35 REMARK 3 ESD FROM SIGMAA (A) : 0.39 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.40 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.52 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.007 REMARK 3 BOND ANGLES (DEGREES) : 1.200 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 23.70 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.740 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.38 REMARK 3 BSOL : 51.14 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 3 : ION.PARAM REMARK 3 PARAMETER FILE 4 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : NULL REMARK 3 TOPOLOGY FILE 3 : NULL REMARK 3 TOPOLOGY FILE 4 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2PA2 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 30-MAY-07. REMARK 100 THE DEPOSITION ID IS D_1000042155. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 18-JUL-06 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 6.4 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SPRING-8 REMARK 200 BEAMLINE : BL41XU REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0000 REMARK 200 MONOCHROMATOR : ROTATED-INCLINED DOUBLE-CRYSTAL REMARK 200 OPTICS : RHODIUM-COATED MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 10870 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.500 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.1 REMARK 200 DATA REDUNDANCY : 5.900 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.05000 REMARK 200 FOR THE DATA SET : 36.6000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.50 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.59 REMARK 200 COMPLETENESS FOR SHELL (%) : 97.0 REMARK 200 DATA REDUNDANCY IN SHELL : 5.90 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.43800 REMARK 200 FOR SHELL : 3.620 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 1S72 CHAIN H REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 43.15 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.16 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 1.0M DI-SODIUM HYDROXYL PHOSPHATE, REMARK 280 1.0M POTASSIUM DIHYDROXYL PHOSPHATE, PH 4.5 100MM SODIUM ACETATE REMARK 280 , PH 6.4, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 293.0K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 31 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+1/3 REMARK 290 3555 -X+Y,-X,Z+2/3 REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z+2/3 REMARK 290 6555 -X,-X+Y,-Z+1/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 61.82967 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 123.65933 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 123.65933 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 61.82967 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 32 REMARK 465 SER A 33 REMARK 465 PHE A 34 REMARK 465 ASP A 35 REMARK 465 LEU A 36 REMARK 465 GLY A 37 REMARK 465 ARG A 38 REMARK 465 LYS A 39 REMARK 465 HIS A 95 REMARK 465 VAL A 96 REMARK 465 ILE A 97 REMARK 465 ARG A 98 REMARK 465 ILE A 99 REMARK 465 ASN A 100 REMARK 465 LYS A 101 REMARK 465 MET A 102 REMARK 465 LEU A 103 REMARK 465 SER A 104 REMARK 465 CYS A 105 REMARK 465 ALA A 106 REMARK 465 GLY A 107 REMARK 465 ALA A 108 REMARK 465 ASP A 109 REMARK 465 ARG A 110 REMARK 465 LEU A 111 REMARK 465 GLN A 112 REMARK 465 THR A 113 REMARK 465 GLY A 114 REMARK 465 MET A 115 REMARK 465 ARG A 116 REMARK 465 GLY A 117 REMARK 465 ALA A 118 REMARK 465 PHE A 119 REMARK 465 GLY A 120 REMARK 465 LYS A 121 REMARK 465 PRO A 122 REMARK 465 GLN A 123 REMARK 465 ASN A 177 REMARK 465 ALA A 178 REMARK 465 ASP A 179 REMARK 465 GLU A 180 REMARK 465 PHE A 181 REMARK 465 GLU A 182 REMARK 465 GLY B 32 REMARK 465 SER B 33 REMARK 465 PHE B 34 REMARK 465 ASP B 35 REMARK 465 LEU B 36 REMARK 465 GLY B 37 REMARK 465 ARG B 38 REMARK 465 LYS B 39 REMARK 465 HIS B 95 REMARK 465 VAL B 96 REMARK 465 ILE B 97 REMARK 465 ARG B 98 REMARK 465 ILE B 99 REMARK 465 ASN B 100 REMARK 465 LYS B 101 REMARK 465 MET B 102 REMARK 465 LEU B 103 REMARK 465 SER B 104 REMARK 465 CYS B 105 REMARK 465 ALA B 106 REMARK 465 GLY B 107 REMARK 465 ALA B 108 REMARK 465 ASP B 109 REMARK 465 ARG B 110 REMARK 465 LEU B 111 REMARK 465 GLN B 112 REMARK 465 THR B 113 REMARK 465 GLY B 114 REMARK 465 MET B 115 REMARK 465 ARG B 116 REMARK 465 GLY B 117 REMARK 465 ALA B 118 REMARK 465 PHE B 119 REMARK 465 GLY B 120 REMARK 465 LYS B 121 REMARK 465 PRO B 122 REMARK 465 GLN B 123 REMARK 465 ASN B 177 REMARK 465 ALA B 178 REMARK 465 ASP B 179 REMARK 465 GLU B 180 REMARK 465 PHE B 181 REMARK 465 GLU B 182 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 42 60.26 -67.21 REMARK 500 PHE A 46 74.33 -115.01 REMARK 500 THR A 140 -164.40 -163.93 REMARK 500 LYS B 42 84.54 -62.71 REMARK 500 PHE B 46 71.91 -116.43 REMARK 500 LYS B 82 -22.70 -38.20 REMARK 500 LYS B 156 -3.75 -58.78 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE K A 1 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE K B 2 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: HSS001003848.1 RELATED DB: TARGETDB DBREF 2PA2 A 34 182 UNP P27635 RL10_HUMAN 34 182 DBREF 2PA2 B 34 182 UNP P27635 RL10_HUMAN 34 182 SEQADV 2PA2 GLY A 32 UNP P27635 EXPRESSION TAG SEQADV 2PA2 SER A 33 UNP P27635 EXPRESSION TAG SEQADV 2PA2 GLY B 32 UNP P27635 EXPRESSION TAG SEQADV 2PA2 SER B 33 UNP P27635 EXPRESSION TAG SEQRES 1 A 151 GLY SER PHE ASP LEU GLY ARG LYS LYS ALA LYS VAL ASP SEQRES 2 A 151 GLU PHE PRO LEU CYS GLY HIS MET VAL SER ASP GLU TYR SEQRES 3 A 151 GLU GLN LEU SER SER GLU ALA LEU GLU ALA ALA ARG ILE SEQRES 4 A 151 CYS ALA ASN LYS TYR MET VAL LYS SER CYS GLY LYS ASP SEQRES 5 A 151 GLY PHE HIS ILE ARG VAL ARG LEU HIS PRO PHE HIS VAL SEQRES 6 A 151 ILE ARG ILE ASN LYS MET LEU SER CYS ALA GLY ALA ASP SEQRES 7 A 151 ARG LEU GLN THR GLY MET ARG GLY ALA PHE GLY LYS PRO SEQRES 8 A 151 GLN GLY THR VAL ALA ARG VAL HIS ILE GLY GLN VAL ILE SEQRES 9 A 151 MET SER ILE ARG THR LYS LEU GLN ASN LYS GLU HIS VAL SEQRES 10 A 151 ILE GLU ALA LEU ARG ARG ALA LYS PHE LYS PHE PRO GLY SEQRES 11 A 151 ARG GLN LYS ILE HIS ILE SER LYS LYS TRP GLY PHE THR SEQRES 12 A 151 LYS PHE ASN ALA ASP GLU PHE GLU SEQRES 1 B 151 GLY SER PHE ASP LEU GLY ARG LYS LYS ALA LYS VAL ASP SEQRES 2 B 151 GLU PHE PRO LEU CYS GLY HIS MET VAL SER ASP GLU TYR SEQRES 3 B 151 GLU GLN LEU SER SER GLU ALA LEU GLU ALA ALA ARG ILE SEQRES 4 B 151 CYS ALA ASN LYS TYR MET VAL LYS SER CYS GLY LYS ASP SEQRES 5 B 151 GLY PHE HIS ILE ARG VAL ARG LEU HIS PRO PHE HIS VAL SEQRES 6 B 151 ILE ARG ILE ASN LYS MET LEU SER CYS ALA GLY ALA ASP SEQRES 7 B 151 ARG LEU GLN THR GLY MET ARG GLY ALA PHE GLY LYS PRO SEQRES 8 B 151 GLN GLY THR VAL ALA ARG VAL HIS ILE GLY GLN VAL ILE SEQRES 9 B 151 MET SER ILE ARG THR LYS LEU GLN ASN LYS GLU HIS VAL SEQRES 10 B 151 ILE GLU ALA LEU ARG ARG ALA LYS PHE LYS PHE PRO GLY SEQRES 11 B 151 ARG GLN LYS ILE HIS ILE SER LYS LYS TRP GLY PHE THR SEQRES 12 B 151 LYS PHE ASN ALA ASP GLU PHE GLU HET K A 1 1 HET K B 2 1 HETNAM K POTASSIUM ION FORMUL 3 K 2(K 1+) FORMUL 5 HOH *35(H2 O) HELIX 1 1 SER A 62 GLY A 81 1 20 HELIX 2 2 ASN A 144 LYS A 156 1 13 HELIX 3 3 PHE A 157 PHE A 159 5 3 HELIX 4 4 SER B 62 GLY B 81 1 20 HELIX 5 5 ASN B 144 LYS B 156 1 13 HELIX 6 6 PHE B 157 PHE B 159 5 3 SHEET 1 A 4 PHE A 85 VAL A 89 0 SHEET 2 A 4 VAL A 134 THR A 140 -1 O ARG A 139 N HIS A 86 SHEET 3 A 4 LEU A 48 SER A 54 -1 N MET A 52 O ILE A 135 SHEET 4 A 4 GLN A 163 SER A 168 -1 O HIS A 166 N HIS A 51 SHEET 1 B 2 GLU A 58 SER A 61 0 SHEET 2 B 2 VAL A 126 VAL A 129 -1 O ALA A 127 N LEU A 60 SHEET 1 C 4 PHE B 85 VAL B 89 0 SHEET 2 C 4 VAL B 134 THR B 140 -1 O ARG B 139 N HIS B 86 SHEET 3 C 4 LEU B 48 SER B 54 -1 N MET B 52 O ILE B 135 SHEET 4 C 4 GLN B 163 SER B 168 -1 O LYS B 164 N VAL B 53 SHEET 1 D 2 GLU B 58 SER B 61 0 SHEET 2 D 2 VAL B 126 VAL B 129 -1 O ALA B 127 N LEU B 60 CISPEP 1 HIS A 92 PRO A 93 0 -0.11 CISPEP 2 HIS B 92 PRO B 93 0 -0.29 SITE 1 AC1 5 LYS A 156 PHE A 159 GLY A 161 GLN A 163 SITE 2 AC1 5 HOH A 199 SITE 1 AC2 4 LYS B 156 PHE B 159 GLY B 161 GLN B 163 CRYST1 52.724 52.724 185.489 90.00 90.00 120.00 P 31 2 1 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.018967 0.010950 0.000000 0.00000 SCALE2 0.000000 0.021901 0.000000 0.00000 SCALE3 0.000000 0.000000 0.005391 0.00000